Compound Evidence File
#EC-2026-0452
BMK ethyl glycidate CAS 41232-97-7
Filed under Raw Materials. The bureau holds 114 laboratory returns for this compound from 47 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
47 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Jan 2026 | 2 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Dec 2025 | 1 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 10.0 | 10.0 | 13 Jan 2026 | 11 Aug 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 9 Nov 2025 | 14 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 10.0 | 10.0 | 28 May 2026 | 21 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Feb 2026 | 1 Apr 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 20 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Feb 2026 | 8 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 14 May 2026 | 2 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Jun 2026 | 3 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 10.0 | 10.0 | 10.0 | 7 May 2026 | 16 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Feb 2026 | 14 Jul 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 | 8 Jul 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 8 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Nov 2025 | 12 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 9.9 | 25 Nov 2025 | 28 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 26 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 2 May 2026 | 1 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 20 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Feb 2026 | 14 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 13 Apr 2026 | 17 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Dec 2025 | 12 Aug 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 9.7 | 9.7 | 9.7 | 3 Jun 2025 | 3 Jun 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 9.6 | 9.6 | 9.6 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 9.5 | 9.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 9.5 | 9.5 | 9.5 | 7 May 2025 | 7 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.9 | 7.4 | 9.9 | 21 May 2026 | 21 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 2 | 8.8 | 7.7 | 10.0 | 2 Apr 2025 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.5 | 7.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.3 | 7.0 | 9.8 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 7.8 | 7.1 | 9.1 | 24 May 2026 | 24 May 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 | 14 Jan 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 1 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 | 24 Apr 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 | 9 Jun 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 | 16 Mar 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 6.6 | 6.6 | 6.6 | 9 Jun 2025 | 9 Jun 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 | 2 Apr 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 | 3 Jul 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 1 | 5.8 | 5.8 | 5.8 | 8 Jul 2025 | 8 Jul 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 5.6 | 5.6 | 5.6 | 20 Jun 2025 | 20 Jun 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 5.1 | 5.1 | 5.1 | 8 Jul 2025 | 8 Jul 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 4.5 | 4.5 | 4.5 | 25 Apr 2025 | 25 Apr 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.3 | 4.3 | 4.3 | 27 Feb 2025 | 27 Feb 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 3.6 | 3.6 | 3.6 | 13 Jun 2025 | 13 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for BMK ethyl glycidate CAS 41232-97-7 alone.